Pantoprazole Sodium Sun (Pantoprazole Sodium Sesquihydrate)

Pantoprazole sodium is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining.
• Erosive oesophagitis: accelerates mucosal healing and reduces further erosion.
• Peptic ulcer disease: supports ulcer healing and prevents recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens (as adjunct): enhances eradication success when combined with antibiotics.

• Pantoprazole sodium binds selectively and irreversibly to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly lowers gastric acidity, allowing damaged mucosa to heal and reducing reflux‑related symptoms.

Pantoprazole sodium may cause a range of adverse reactions. Most are mild and transient, but rare events can be serious.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: usually self‑limiting.
• Nausea or abdominal discomfort.
• Flatulence or bloating.
• Constipation: occasional.
• Dry mouth.

Serious or Rare Side Effects

• Acute interstitial nephritis: presents with renal impairment.
• Severe hypersensitivity reactions: including rash, angioedema or anaphylaxis.
• Clostridioides difficile‑associated diarrhoea.
• Osteoporotic fractures: linked to long‑term use.
• Vitamin B12 deficiency: may develop with prolonged therapy.
• Hepatic enzyme elevations: transient increases in ALT/AST.

Before initiating therapy, consider patient‑specific factors and monitor appropriately.

• Renal impairment: dose adjustment may be required.
• Hepatic impairment: use with caution in moderate disease.
• Elderly patients: monitor for fracture risk with long‑term use.
• Concomitant use of drugs that increase gastric pH: assess need for dose timing.
• Pregnancy and lactation: only use if clearly indicated after risk‑benefit assessment.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Pantoprazole sodium can affect the absorption or metabolism of several medicines. Interaction management depends on clinical significance.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption may compromise efficacy.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma levels.
• Clopidogrel: reduced conversion to active metabolite, potentially lowering antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: may increase INR; monitor coagulation parameters.
• Methotrexate: possible accumulation; check serum levels.
• Digoxin: slight increase in serum concentration; observe for toxicity.
• Oral contraceptives: may reduce hormonal efficacy; advise backup contraception.